3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Motor Activity
3
Sleep Wake Disorders
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Cancer, Papillary
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Head and Neck Squamous Cell Carcinoma
1
Kidney Neoplasms
1
Hematopoietic and Lymphatic System Neoplasm
1
Hematologic Neoplasms
1
Head and Neck Carcinoma
1
Fatigue
1
Endometrial Neoplasms
1
Depressive Disorder
1
Depression
1
Castration-Resistant Prostate Cancer (CRPC)
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Carcinoma In Situ
1
Anxiety Disorders
1
Interventions
Rituximab
5
Specimen Handling
3
Biopsy
3
ibrutinib
2
binimetinib
2
Vemurafenib
2
Cyclophosphamide
2
Cladribine
2
venetoclax
1
tovorafenib
1
polatuzumab vedotin
1
pembrolizumab
1
obinutuzumab
1
immunotoxin HA22
1
fludarabine phosphate
1
fludarabine
1
encorafenib
1
acalabrutinib
1
Whole-Body Irradiation
1
Transplantation
1
Tacrolimus
1
Spinal Puncture
1
Radiotherapy
1
Prednisone
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Magnetic Resonance Spectroscopy
1
Lenalidomide
1
High-Energy Shock Waves
1
Famotidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Hairy Cell
×
Counseling
×
90 days
×
Clear all
No trials found.